Shares in British biopharmaceutical firm Mereo Biopharma ($MREO) saw a wipeout of over 90% on Monday after two of its ...
Investor's Business Daily on MSN
Stock market today: Dow, Nasdaq struggle; these biopharma names make giant moves (live coverage)
The Dow Jones Industrial Average and other major indexes fell Monday afternoon as investors sold holdings in this ...
Investing.com -- Mereo BioPharma Group plc (NASDAQ:MREO) stock plunged 90.3% on Monday after the company announced that its Phase 3 clinical trials for setrusumab in Osteogenesis Imperfecta failed to ...
Cytokinetics is a late-stage biopharmaceutical company targeting muscle function. Its stock has gained almost 30% this year, ...
Recent Alzheimer's drug approvals have put the biopharma industry back in the spotlight. Bank of America names seven stocks to buy to ride the trend.
(RTTNews) - Risk runs high, but so does the upside. Biotech investing thrives on bold bets and breakthrough data. On October 30, 2025, a wave of clinical-stage and commercial biopharma stocks surged ...
Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to ...
TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback